8:00 am
Salon C

Opening Plenary: Bioethical Challenges of the 21st Century

• Wayne Shelton, Ph.D., Director, Program on Ethics & Health Outcomes, Alden March Bioethics Institute

9:00 am
Concurrent Session One
Salon D

Corporate Showcase I: Emerging Companies

Innovation is the hallmark of small entrepreneurial firms, and Long Island has a proven tradition of innovation. Executives from several of Long Island’s most promising new companies discuss the technologies and business strategies that will make them industry leaders.

• Daniel Grande, M.D., Tissue Genesis Inc.
• Tom Higgins, President, NBS Technology, LLC
. Ben Liang, Ph.D., Strategic Technology Development Officer, Applied DNA Sciences, Inc.
. Yi-Xian Qin, Ph.D., Co-Founder, AcousticScan, Inc.

Moving Into Clinical Trials: What Every Life Sciences Company Should Know

The majority of life sciences companies in the region are early stage firms pursuing research and development activities to move their products and services towards market. For new therapeutics and diagnostics, the FDA regulated clinical trial process is a significant and expensive barrier to market entry. Experts will provide companies with insights into preparing for human testing and gearing up for working with the FDA.

Moderator: Suzanne LoGalbo, Thompson Hine
• Marilyn Corretto, Small Business Representative, U.S. FDA (Invited)
• Jules Mitchel, Ph.D., President, Target Health, Inc. (Invited)
. Jeff Peacock, E-Z-EM, Inc. (Invited)
• John Talarico, VP, Regulatory and Clinical Affairs, ProRythym, Inc. (Invited)
•Jeffrey Yablon, President, PharmaScan Clinical Trials LLC

Translational Research, Intellectual Property, and the Critical Path to Market

There remains a significant gap between intellectual property generated at an academic institution, and the commercialization of technology by a life science company. The development and management of intellectual property, as well as the role of translational research to drive commercialization will be discussed. IP valuation, IP marketing strategies, estimating market potential, and critical path management will be considered, as well as the identification of funding sources to support novel product development efforts.

Moderator: Clinton Rubin, Ph.D., Director, Center for Biotechnology
• Michael Bielski, J.D., ipCapital Group, Inc.
• Peter DeLuca, J.D., Partner, Carter, DeLuca, Farrell & Schmidt, LLP
. Tedd Fenn, Cold Spring Harbor Laboratory
• Kevin Tracy, M.D., Ph.D., Director, Feinstein Institute for Medical Research (Invited)

Corporate Showcase II: Expanding Companies

The life sciences industry reflects a pipeline of companies from early-stage start-ups to Fortune 500 corporations. Learn about companies that are poised for exponential growth as leaders from several of New York’s expanding life science firms discuss their products and their future.

Moderator: Sarah Hewitt, Brown Raysman Millstein Felder & Steiner
. Valerie Alliger-Bograd, Frontier Pharmaceuticals
• Larry Siebert, CEO, ChemBio Diagnostics, Inc.
. David Smith, ProRythm, Inc. (Invited)

10:30 am
Concurrent Session Two
Salon A

Moderator: Anil Dhundale, Ph.D., Director of Scientific Affairs, Center for Biotechnology
• Louis Pena, Ph.D., Brookhaven National Laboratory
• Representative, Cold Spring Harbor Laboratory (Invited)
• Representative, Feinstein Institute for Medical Research (Invited)
• Representative, Stony Brook University (Invited)
• Representative, Winthrop University Hospital (Invited)

Local and State Government Support of the Life Sciences Industry

Moderator: Michael Watt, Executive Director, Long Island Partnership
• Roger Biagi, Director of Government Relations, NYSTAR
• Lisa Broughton, Bio/High Tech Development Specialist, Department of Economic Development, Suffolk County
. Barry Greenspan, Empire State Development
• Michael Schaffield, Department of Economic Development, Nassau County
• Representative, Town of North Hempstead (Invited)

Luncheon Keynote: "The View from 2030 - The Future of the Life Sciences:
Richard Worzel - Leading Futurist & Best Selling Author

Corporate Showcase III: Expanding/Established Firms

The retention of expanding companies is vital to the future success of the life sciences community in the region. Several firms are committed to local development for continued access to the resources Long Island and the surrounding region has to offer the life sciences industry. Learn about companies that are poised for exponential growth as leaders from several of New York’s expanding life science firms discuss their products and their plans for growth.

Moderator: Martin Hirko, Gilbane Building Corporation (Invited)
. Representative, Misonix Inc.
. Representative, Fonar Inc.
. Representative, Advanced BioPhotonics, Inc. (Invited)
. Representative, Estee Lauder (Invited)
. Joe Ceccoli, General Manager, Engelhard Corporation Long Island (Invited)
• Mitchel Goldberg, Ortek Therapeutics (Invited)

Closing Plenary: "Mobilizing the Region's Assets to Find a Cure"
Father Tom Hartman, God Squad

Closing Remarks

LILSI continues to pursue an aggressive legislative agenda of benefit to the regional and statewide life sciences community. The strategic vision for the future will be presented, as well as the success metrics and programmatic recommendations the organization advocates.

• Joseph Scaduto, Executive Director, Long Island Life Sciences Initiative (LILSI)
• James Hayward, Ph.D., Founder, BioCogent Inc.; Chairman, LILSI